All > Tricuspid Regurgitation

Transcatheter Tricuspid Valve Reconstruction for Tricuspid Regurgitation

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Tricuspid RegurgitationTranscatheter Tricuspid Valve Reconstruction - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test the safety and performance of a new device to treat tricuspid valve disease.

Eligible Conditions
  • Tricuspid Regurgitation

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
CorMatrix Cor TRICUSPID ECM Valve
2
GIE Medical ProTractX3 TTS DCB
1
ommitence of defibrillation testing

Study Objectives

2 Primary · 7 Secondary · Reporting Duration: 30 days, 6 Months, 12 Months

30 days
Clinical Success
Composite Major Adverse Event (MAE) Rate
Freedom from device or procedure-related adverse events
Month 12
Health Status
Six minute walk test
Month 12
NYHA Functional Class
Reduction in TR grade
Discharge (2-7 days)
Procedural Success
Intraprocedural
Device Success

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
CorMatrix Cor TRICUSPID ECM Valve
3
GIE Medical ProTractX3 TTS DCB
1
ommitence of defibrillation testing

Trial Design

1 Treatment Group

Treatment
1 of 1

Experimental Treatment

55 Total Participants · 1 Treatment Group

Primary Treatment: Transcatheter Tricuspid Valve Reconstruction · No Placebo Group · N/A

Treatment
Device
Experimental Group · 1 Intervention: Transcatheter Tricuspid Valve Reconstruction · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 30 days, 6 months, 12 months

Who is running the clinical trial?

Edwards LifesciencesLead Sponsor
164 Previous Clinical Trials
57,865 Total Patients Enrolled
William Gray, MDPrincipal InvestigatorLankenau Heart
8 Previous Clinical Trials
3,307 Total Patients Enrolled
Firas Zahr, MDPrincipal InvestigatorOregon Health and Science University

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
The local site determines that the patient is appropriate for transcatheter tricuspid reconstruction.
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top